Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05479552

A Diagnostic Test for Dementia With Lewy Bodies

Sponsor: CND Life Sciences

View on ClinicalTrials.gov

Summary

The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.

Key Details

Gender

All

Age Range

50 Years - 85 Years

Study Type

OBSERVATIONAL

Enrollment

80

Start Date

2022-08-15

Completion Date

2025-10-31

Last Updated

2025-01-15

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Syn-One Test

CND Life Sciences is expanding the utility of its diagnostic technology, the Syn-One Test, to pathologically distinguish between early DLB and Alzheimer's disease to prevent misdiagnoses and establish the relationship between progression and α-synuclein deposition by measuring α- synuclein accumulation in patient's nerve fibers using a simple skin punch biopsy.

Locations (12)

CND Life Sciences

Scottsdale, Arizona, United States

University of California San Diego

La Jolla, California, United States

CenExel RMCR

Englewood, Colorado, United States

University of Miami

Boca Raton, Florida, United States

Neurology One

Winter Park, Florida, United States

Ochsner Research

New Orleans, Louisiana, United States

Mass General Hospital

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Headlands Research

Plymouth, Massachusetts, United States

University of Michigan

Ann Arbor, Michigan, United States

Vanderbilt University Medical Center

Nashville, Tennessee, United States

University of Utah

Salt Lake City, Utah, United States